Complete formalities on Novartis patent claim: SC
The Supreme Court today directed the Centre, pharma major Cipla, Ranbaxy Lab, Hetero Drugs, Natco Pharma and others to complete their pleadings in the matter of Swiss firm Novartis AG challenging denial of patent for its blood cancer drug Glivec.
Read more on Business Standard India
Orignal From: Complete formalities on Novartis patent claim: SC
Post a Comment